Established in 2009, Xiamen XinLong Biomedical Co.,Ltd, is a vertically integrated high-technology pharmaceutical company in China. Xinlong is the leading API manufacturer of olanzapine Imatinib Meylate S-amlodipine,Irinotecan hydrochloride tranilast and Capecitaine.Meanwhile Dapoxetine and rosuvastin intermediate are also our strong products. Perfect organization, R&D, production, quality assurance, regulatory support, , cultural, and sales management system make Xinlong will be one of competitive biomedical enterprises in Fujian Province. Xinlong¡¯s mission is to become the leading enterprise in biomedical business and supply biomedical support for our clients.in the world. "Focusing on product quality,serving the customer"is our forever principle. We cooperate sincerely with the global pharmaceutical industry and work together in serving human health undertaking!